Hannah L Nicholls
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hannah L Nicholls has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Kumar Gupta
William Harvey Research Institute, Queen Mary University of London
1 shared publication - Claudia Paola Cabrera
Queen Mary University London
1 shared publication - Fu Liang Ng
St Bartholomew's and the Royal London Hospitals Barts Health NHS Trust UK
1 shared publication - Mark Jonathan Caulfield
William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK
1 shared publication - Michael R. Barnes
Queen Mary University of London
1 shared publication - Patricia B. Munroe
William Harvey Research Institute, Barts and the London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK
1 shared publication
Latest Publications
- Open Access
- 21 November 2019
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (R2) , R151-R161
Over 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated
High blood pressure (BP) remains the major heritable and modifiable risk factor for cardiovascular disease. Persistent high BP, or hypertension, is a complex trait with both genetic and environmental interactions. Despite swift advances in genomics, translating new discoveries to further our understanding of the underlying molecular mechanisms remains a challenge. More than 500 loci implicated in the regulation of BP have been revealed by genome-wide association studies (GWAS) in 2018 alone, taking the total number of BP genetic loci to over 1000. Even with the large number of loci now associated to BP, the genetic variance explained by all loci together remains low (~5.7%). These genetic associations have elucidated mechanisms and pathways regulating BP, highlighting potential new therapeutic and drug repurposing targets. A large proportion of the BP loci were discovered and reported simultaneously by multiple research groups, creating a knowledge gap, where the reported loci to date have not been investigated in a harmonious way. Here, we review the BP-associated genetic variants reported across GWAS studies and investigate their potential impact on the biological systems using in silico enrichment analyses for pathways, tissues, gene ontology and genetic pleiotropy.
- 21 November 2019
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (R2) , R151-R161
Open AccessOver 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated
High blood pressure (BP) remains the major heritable and modifiable risk factor for cardiovascular disease. Persistent high BP, or hypertension, is a complex trait with both genetic and environmental interactions. Despite swift advances in genomics, translating new discoveries to further our understanding of the underlying molecular mechanisms remains a challenge. More than 500 loci implicated in the regulation of BP have been revealed by genome-wide association studies (GWAS) in 2018 alone, taking the total number of BP genetic loci to over 1000. Even with the large number of loci now associated to BP, the genetic variance explained by all loci together remains low (~5.7%). These genetic associations have elucidated mechanisms and pathways regulating BP, highlighting potential new therapeutic and drug repurposing targets. A large proportion of the BP loci were discovered and reported simultaneously by multiple research groups, creating a knowledge gap, where the reported loci to date have not been investigated in a harmonious way. Here, we review the BP-associated genetic variants reported across GWAS studies and investigate their potential impact on the biological systems using in silico enrichment analyses for pathways, tissues, gene ontology and genetic pleiotropy.